{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:26:16Z","timestamp":1773300376650,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"vor","delay-in-days":3885,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s13311-012-0165-2","type":"journal-article","created":{"date-parts":[[2013,1,7]],"date-time":"2013-01-07T09:06:04Z","timestamp":1357549564000},"page":"143-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Neuroprotective and Anti-inflammatory Properties of a Coffee Component in the MPTP Model of Parkinson's Disease"],"prefix":"10.1016","volume":"10","author":[{"given":"Kang-Woo","family":"Lee","sequence":"first","affiliation":[]},{"given":"Joo-Young","family":"Im","sequence":"additional","affiliation":[]},{"given":"Jong-Min","family":"Woo","sequence":"additional","affiliation":[]},{"given":"Hilary","family":"Grosso","sequence":"additional","affiliation":[]},{"given":"Yoon-Seong","family":"Kim","sequence":"additional","affiliation":[]},{"given":"Ana Clara","family":"Cristovao","sequence":"additional","affiliation":[]},{"given":"Patricia K.","family":"Sonsalla","sequence":"additional","affiliation":[]},{"given":"David S.","family":"Schuster","sequence":"additional","affiliation":[]},{"given":"Marla M.","family":"Jalbut","sequence":"additional","affiliation":[]},{"given":"Jose R.","family":"Fernandez","sequence":"additional","affiliation":[]},{"given":"Michael","family":"Voronkov","sequence":"additional","affiliation":[]},{"given":"Eunsung","family":"Junn","sequence":"additional","affiliation":[]},{"given":"Steven P.","family":"Braithwaite","sequence":"additional","affiliation":[]},{"given":"Jeffry B.","family":"Stock","sequence":"additional","affiliation":[]},{"given":"M. Maral","family":"Mouradian","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"Suppl 3","key":"10.1007\/s13311-012-0165-2_bib1","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1002\/ana.10483","article-title":"Oxidative stress in Parkinson's disease","volume":"53","author":"Jenner","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-012-0165-2_bib2","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson's disease: a target for neuroprotection?","volume":"8","author":"Hirsch","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-012-0165-2_bib3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrneurol.2010.17","article-title":"Microglia in neurodegenerative disease","volume":"6","author":"Perry","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"10.1007\/s13311-012-0165-2_bib4","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1086\/301812","article-title":"Mitochondrial dysfunction in idiopathic Parkinson disease","volume":"62","author":"Parker","year":"1998","journal-title":"Am J Hum Genet"},{"issue":"Suppl 1","key":"10.1007\/s13311-012-0165-2_bib5","first-page":"35","article-title":"Mechanisms of MPTP toxicity","volume":"13","author":"Przedborski","year":"1998","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-012-0165-2_bib6","doi-asserted-by":"crossref","first-page":"6963","DOI":"10.1523\/JNEUROSCI.6513-10.2011","article-title":"Enhanced phosphatase activity attenuates alpha-Synucleinopathy in a mouse model","volume":"31","author":"Lee","year":"2011","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-012-0165-2_bib7","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1001\/jama.283.20.2674","article-title":"Association of coffee and caffeine intake with the risk of Parkinson disease","volume":"283","author":"Ross","year":"2000","journal-title":"JAMA"},{"key":"10.1007\/s13311-012-0165-2_bib8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ana.1052","article-title":"Prospective study of caffeine consumption and risk of Parkinson's disease in men and women","volume":"50","author":"Ascherio","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-012-0165-2_bib9","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/aje\/kwh312","article-title":"Coffee consumption, gender, and Parkinson's disease mortality in the cancer prevention study II cohort: the modifying effects of estrogen","volume":"160","author":"Ascherio","year":"2004","journal-title":"Am J Epidemiol"},{"issue":"Suppl 1","key":"10.1007\/s13311-012-0165-2_bib10","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.3233\/JAD-2010-091525","article-title":"Caffeine exposure and the risk of Parkinson's disease: a systematic review and meta-analysis of observational studies","volume":"20","author":"Costa","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1007\/s13311-012-0165-2_bib11","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1056\/NEJMoa1112010","article-title":"Association of coffee drinking with total and cause-specific mortality","volume":"366","author":"Freeman","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-012-0165-2_bib12","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.1523\/JNEUROSCI.4777-09.2010","article-title":"Decaffeinated coffee and nicotine-free tobacco provide neuroprotection in Drosophila models of Parkinson's disease through an NRF2-dependent mechanism","volume":"30","author":"Trinh","year":"2010","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-012-0165-2_bib13","doi-asserted-by":"crossref","first-page":"e29935","DOI":"10.1371\/journal.pone.0029935","article-title":"Apoptosis signal-regulating kinase 1 mediates MPTP toxicity and regulates glial activation","volume":"7","author":"Lee","year":"2012","journal-title":"PLoS One"},{"key":"10.1007\/s13311-012-0165-2_bib14","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/ar.1092310411","article-title":"Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator","volume":"231","author":"West","year":"1991","journal-title":"Anat Rec"},{"key":"10.1007\/s13311-012-0165-2_bib15","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S0022-3565(25)39183-4","article-title":"Characteristics of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the mouse","volume":"242","author":"Sonsalla","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1007\/s13311-012-0165-2_bib16","doi-asserted-by":"crossref","first-page":"10982","DOI":"10.1523\/JNEUROSCI.23-34-10982.2003","article-title":"Adenosinergic protection of dopaminergic and GABAergic neurons against mitochondrial inhibition through receptors located in the substantia nigra and striatum, respectively","volume":"23","author":"Alfinito","year":"2003","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-012-0165-2_bib17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00001756-200302100-00005","article-title":"Extracellular and intracellular glutathione protects astrocytes from Zn2 + \u2212induced cell death","volume":"14","author":"Kim","year":"2003","journal-title":"Neuroreport"},{"key":"10.1007\/s13311-012-0165-2_bib18","doi-asserted-by":"crossref","first-page":"615","DOI":"10.4049\/jimmunol.0903480","article-title":"Alpha-synuclein activates microglia by inducing the expressions of matrix metalloproteinases and the subsequent activation of protease-activated receptor-1","volume":"185","author":"Lee","year":"2010","journal-title":"J Immunol"},{"key":"10.1007\/s13311-012-0165-2_bib19","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/70978","article-title":"Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease","volume":"5","author":"Liberatore","year":"1999","journal-title":"Nat Med"},{"key":"10.1007\/s13311-012-0165-2_bib20","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002","article-title":"Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease","volume":"22","author":"Wu","year":"2002","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-012-0165-2_bib21","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00019052-200108000-00009","article-title":"The role of glial cells in Parkinson's disease","volume":"14","author":"Vila","year":"2001","journal-title":"Curr Opin Neurol"},{"key":"10.1007\/s13311-012-0165-2_bib22","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0006-2952(00)00424-X","article-title":"Type 2A protein phosphatase, the complex regulator of numerous signaling pathways","volume":"60","author":"Zolnierowicz","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"10.1007\/s13311-012-0165-2_bib23","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1042\/bj3530417","article-title":"Protein phosphatase 2A: a highly regulated family of serine\/threonine phosphatases implicated in cell growth and signalling","volume":"353","author":"Janssens","year":"2001","journal-title":"Biochem J"},{"key":"10.1007\/s13311-012-0165-2_bib24","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.biochi.2003.09.004","article-title":"Serine\/threonine protein phosphatases PP1 and PP2A are key players in apoptosis","volume":"85","author":"Garcia","year":"2003","journal-title":"Biochimie"},{"key":"10.1007\/s13311-012-0165-2_bib25","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.molcel.2009.02.015","article-title":"From promiscuity to precision: protein phosphatases get a makeover","volume":"33","author":"Virshup","year":"2009","journal-title":"Mol Cell"},{"key":"10.1007\/s13311-012-0165-2_bib26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrn2038","article-title":"Microglia-mediated neurotoxicity: uncovering the molecular mechanisms","volume":"8","author":"Block","year":"2007","journal-title":"Nat Rev Neurosci"},{"key":"10.1007\/s13311-012-0165-2_bib27","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1023\/B:JOBB.0000041771.66775.d5","article-title":"MPTP as a mitochondrial neurotoxic model of Parkinson's disease","volume":"36","author":"Przedborski","year":"2004","journal-title":"J Bioenerg Biomembr"},{"key":"10.1007\/s13311-012-0165-2_bib28","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1089\/ars.2005.7.685","article-title":"Reactive oxygen and nitrogen species: weapons of neuronal destruction in models of Parkinson's disease","volume":"7","author":"Przedborski","year":"2005","journal-title":"Antioxid Redox Signal"},{"key":"10.1007\/s13311-012-0165-2_bib29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0925-4439(97)00070-7","article-title":"Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease","volume":"1362","author":"Cassarino","year":"1997","journal-title":"Biochim Biophys Acta"},{"key":"10.1007\/s13311-012-0165-2_bib30","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0002-9440(10)64553-1","article-title":"Alpha-synuclein promotes mitochondrial deficit and oxidative stress","volume":"157","author":"Hsu","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1007\/s13311-012-0165-2_bib31","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0304-3940(02)00016-2","article-title":"Human alpha-synuclein over-expression increases intracellular reactive oxygen species levels and susceptibility to dopamine","volume":"320","author":"Junn","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1007\/s13311-012-0165-2_bib32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1006\/abbi.1995.1263","article-title":"Sublethal levels of oxidant stress stimulate multiple serine\/threonine kinases and suppress protein phosphatases in Jurkat T cells","volume":"319","author":"Whisler","year":"1995","journal-title":"Arch Biochem Biophys"},{"key":"10.1007\/s13311-012-0165-2_bib33","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0006-291X(02)00268-1","article-title":"Regulation of protein phosphatase 2A by hydrogen peroxide and glutathionylation","volume":"293","author":"Rao","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1007\/s13311-012-0165-2_bib34","doi-asserted-by":"crossref","first-page":"37497","DOI":"10.1074\/jbc.M211739200","article-title":"Constitutive induction of p-Erk1\/2 accompanied by reduced activities of protein phosphatases 1 and 2A and MKP3 due to reactive oxygen species during cellular senescence","volume":"278","author":"Kim","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-012-0165-2_bib35","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.neulet.2009.11.010","article-title":"Chronic oxidative stress causes increased tau phosphorylation in M17 neuroblastoma cells","volume":"468","author":"Su","year":"2010","journal-title":"Neurosci Lett"},{"key":"10.1007\/s13311-012-0165-2_bib36","doi-asserted-by":"crossref","first-page":"966","DOI":"10.4049\/jimmunol.166.2.966","article-title":"The serine\/threonine phosphatase, PP2A: endogenous regulator of inflammatory cell signaling","volume":"166","author":"Shanley","year":"2001","journal-title":"J Immunol"},{"key":"10.1007\/s13311-012-0165-2_bib37","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1242\/jcs.02481","article-title":"Alpha-synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells","volume":"118","author":"Peng","year":"2005","journal-title":"J Cell Sci"},{"key":"10.1007\/s13311-012-0165-2_bib38","doi-asserted-by":"crossref","first-page":"17648","DOI":"10.1074\/jbc.M110.100867","article-title":"Serine 129 phosphorylation reduces the ability of alpha-synuclein to regulate tyrosine hydroxylase and protein phosphatase 2A in vitro and in vivo","volume":"285","author":"Lou","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-012-0165-2_bib39","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/jnen\/63.10.1080","article-title":"Downregulation of protein phosphatase 2A carboxyl methylation and methyltransferase may contribute to Alzheimer disease pathogenesis","volume":"63","author":"Sontag","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"issue":"Suppl 1","key":"10.1007\/s13311-012-0165-2_bib40","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.3233\/JAD-2010-1404","article-title":"Caffeine as a protective factor in dementia and Alzheimer's disease","volume":"20","author":"Eskelinen","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1007\/s13311-012-0165-2_bib41","doi-asserted-by":"crossref","first-page":"821","DOI":"10.4155\/fmc.11.47","article-title":"Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer's disease","volume":"3","author":"Voronkov","year":"2011","journal-title":"Future Med Chem"},{"issue":"6","key":"10.1007\/s13311-012-0165-2_bib42","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.neuint.2012.01.031","article-title":"Targeting phosphatases as the next generation of disease modifying therapeutics for Parkinson's disease","volume":"61","author":"Braithwaite","year":"2012","journal-title":"Neurochem Int"},{"key":"10.1007\/s13311-012-0165-2_bib43","doi-asserted-by":"crossref","first-page":"RC143","DOI":"10.1523\/JNEUROSCI.21-10-j0001.2001","article-title":"Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease","volume":"21","author":"Chen","year":"2001","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-012-0165-2_bib44","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/WNF.0b013e31815a3f03","article-title":"Caffeine and progression of Parkinson disease","volume":"31","author":"Simon","year":"2008","journal-title":"Clin Neuropharmacol"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-012-0165-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13311-012-0165-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923017075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923017075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-012-0165-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:07:33Z","timestamp":1761808053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923017075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S1878747923017075"],"URL":"https:\/\/doi.org\/10.1007\/s13311-012-0165-2","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroprotective and Anti-inflammatory Properties of a Coffee Component in the MPTP Model of Parkinson's Disease","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-012-0165-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}